2009 January 14 cable on Poland pharmaceutical reimbursement list

This is one of several Wikileaks cables on Poland pharmaceutical reimbursements.

Some highlights from this cable:

  • Pfizer’s head of government affairs estimated it contains about 10 new molecules without generic competitors. Meaningful access to the Polish market often hinges on a drug appearing on the list, since those drugs are subsidized by the National Health Fund (NFZ) and doctors most often prescribe drugs from the list.
  • Continue Reading

Jan 2009, Ranneberger reports on Kenya anti-counterfeit goods legislation

September 3, 2011
From KEI staff review of Wikileaks cables (/wikileaks)

The following is a January 2009 cable written by Michael E. Ranneberger, the U.S. Ambassador to Kenya. The subject of the cable is: Kenya Passes Long Awaited Anti-counterfeit Goods Bill

http://cablegatesearch.net/cable.php?id=09NAIROBI86

Cable reference id: #09NAIROBI86

Reference id aka Wikileaks id #186907 ???
Subject Kenya Passes Long Awaited Anti-counterfeit Goods Bill
Origin Embassy Nairobi (Kenya)
Continue Reading

Wikileaks cables on the US opposition to Philippines legislation on affordable medicines

From KEI staff review of Wikileaks cables (/wikileaks)

From September 19, 2005 to January 15, 2010, the US Department of State sent dozens of cables from Manila reporting on disputes in the Philippines regarding IPR and the pricing of pharmaceutical drugs. Much of the U.S. advocacy in the Philippines was done in close cooperation with Pfizer.

Continue Reading

Uncategorized

Implementing the Jordan FTA rules on exclusive rights in regulatory test data

September 2, 2011
From KEI staff review of Wikileaks cables (/wikileaks)

On August 30, 2011, Wikileaks published a December 19, 2005 cable written by Daniel Rubinstein. The cable illustrates the degree to which the U.S. Department of State monitors the implementation of the Jordan-US FTA agreement, as regards disputes over rules on data exclusivity.

Continue Reading

Uncategorized

May 18 2009 cable regarding meeting between US Ambassador and pharma execs in Turkey

September 2, 2011
From KEI staff review of Wikileaks cables (/wikileaks)

In this May 18, 2009 cable, US Ambassador to Turkey James Franklin Jeffrey (currently the US Ambassador to Iraq) met with pharmaceutical company officials, and promised to pressure Turkey to adopt pro-industry changes in regulatory and procurement policies, as well as industry backed policies on patent protection and data exclusivity.

Continue Reading

Wikileaks: US Cable on WIPO SCCR 17 meeting

September 2, 2011
From KEI staff review of Wikileaks cables (/wikileaks)

This is a US Department of State cable reporting on the WIPO SCCR 17 meeting, which took place November 3-7, 2008. This was the first meeting focusing primarily on copyrigh limitations and exceptions, and also, the meeting where the World Blind Union first presented its proposal for a treaty.

Among the observations reported in the cable:

2008 May 14 Cable: Poland wants to cap drug cost effectiveness at 3x GDP/pop. Pfizer wants 6x

September 3, 2011 From KEI staff review of Wikileaks cables (/wikileaks) On May 14, 2008, The US Embassy in Warsaw sent a cable that discussed additions to the list of pharmaceutical products reimbursed by the government. A few highlights from… Continue Reading

The Johnson & Johnson Acuvue Compulsory License

In April of 2010, District Judge Timothy J. Corrigan (M.D Florida, Jacksonville division) declined to grant a permanent injunction following a finding that the Johnson & Johnson’s ACUVUE®OASYS contact lens product infringed patents owned by CIBA Vision Corporation, providing another example of, in effect, a judicial compulsory license following the 2006 eBay v. MercExchange case; the judge wrote:

Continue Reading